JO
MBII

John Overdeck’s Marrone Bio Innovations, Inc. MBII Stock Holding History

John Overdeck’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-70,138
Closed -$51K – 4767
2021
Q4 		$51K Buy
70,138
+6,330
+10% +$5.12K ﹤0.01% 4140
2021
Q3 		$57K Sell
63,808
-114,132
-64% -$137K ﹤0.01% 4144
2021
Q2 		$295K Buy
177,940
+14,171
+9% +$23.7K ﹤0.01% 3528
2021
Q1 		$342K Buy
+163,769
New +$340K ﹤0.01% 3237

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

John Overdeck's MBII Position: Q1 2022 in Review

John Overdeck sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2022, closing a stake of 70,138 shares — an estimated $51K sold.

John Overdeck first reported a position in MBII in Q1 2021 and held it in 4 quarters. The position peaked at $342K in Q1 2021. 71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • John Overdeck reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2022 after selling out during the quarter.
  • John Overdeck sold 70,138 Marrone Bio Innovations, Inc. shares in Q1 2022, an estimated $51K.
  • John Overdeck first reported a position in Marrone Bio Innovations, Inc. in Q1 2021 and held it in 4 quarters.
  • John Overdeck's Marrone Bio Innovations, Inc. position peaked at $342K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.